An Indian COVID-19 vaccine made by Bharat Biotech is set to enter human trials

Business Insider India
Bharat Biotech’s coronavirus vaccine Covaxin is the first COVID-19 vaccine to get DGCI’s (Drug Controller General of India) nod.

The drug regulatory body allowed the pharma company to conduct phase I and phase-II clinical trials.

The vaccine was developed in collaboration with the National Institute of Virology, IndianCouncil of Medical Research (ICMR).

The human trials of Covaxin…